Clinical trial · Observational
Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Prospective Observational Cohort Registry for Patients With Acute Lymphoblastic Leukemia at Asan Medical Center
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The PI resigned the institute, and the rest investigators at the institute decided to terminate the study.
Summary
Brief summary (as posted)
The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for acute lymphoblastic leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia, Acute Lymphoblastic | Acute Lymphoblastic Leukemia | ONTOLOGY_EXACT | 0.98 |
| Leukemia, Biphenotypic, Acute | Leukemia | ONTOLOGY_EXACT | 0.85 |
| Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Leukemia | ONTOLOGY_EXACT | 0.85 |
| Lymphoblastic Lymphoma | Lymphoblastic Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Precursor B-Cell Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnosed as ALL | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Ph-ALL
- description
- Diagnosed as ALL with Philadelphia-negative
- interventionNames
- Other: Diagnosed as ALL
- label
- Ph+ALL
- description
- Diagnosed as ALL with Philadelphia-positive (including biphenotypic acute leukemia with Philadelphia-positive)
- interventionNames
- Other: Diagnosed as ALL
- label
- Other ALL
- description
- Diagnosed as ALL of other type, including Burkitt leukemia
- interventionNames
- Other: Diagnosed as ALL
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * All patients who are diagnosed and/or treated as acute lymphoblastic leukemia at Asan Medical Center (including biphenotypic acute leukemia with Philadelphila-positive, Burkitt leukemia/lymphoma) * 15 years of age and over * All patients who give written consent according to guidelines at Asan Medical Center committee on human research Exclusion Criteria: * Patients who refuse to give consent to registering
References
Publications (0)
Data not yet available